PMHC – NEO / OZM-058

Trial Description: 
A Phase II, Open-Label, Randomized, Multi-Centre Study of Neoadjuvant Olaparib in Patients with Platinum Sensitive Recurrent High Grade Serous Ovarian/Primary Peritoneal or Fallopian tube Cancer
Lead Cooperative Group: 
Disease Site: 
Ovarian
Trial Status: 
Recruiting
Contact person: